Replimune
Replimune Group, based in Massachusetts, is a company specializing in cancer therapy and developing immunotherapies that focus on improving anti-tumor effects of the chosen, patient specific immunotherapy as well as the potency of the immune systems response.
Last updated on
About Replimune
Founded
2015Estimated Revenue
$1M-$10MEmployees
251-1KFunding / Mkt. Cap
$376MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
541Location
City
WoburnState
MassachusettsCountry
United StatesReplimune
Find your buyer within Replimune